CRISPR/Cas9-mediated gene repair in the COL7A1 gene

被引：0
|
作者：
Hainzl, S. [1 ]
Kocher, T. [1 ]
Murauer, E. M. [1 ]
Larcher, F. [4 ,5 ]
Steiner, M. [3 ]
Bauer, J. W. [2 ]
Reichelt, J. [1 ]
Koller, U. [1 ]
机构：
[1] Paracelsus Med Univ, Univ Hosp, Res Program Mol Therapy Genodermatoses, Dept Dermatol,EB House Austria, Salzburg, Austria
[2] Paracelsus Med Univ, Dept Dermatol, Salzburg, Austria
[3] CIEMAT, Epithelial Biomed Div, Madrid, Spain
[4] Paracelsus Med Univ Salzburg, Med Dept 3, Salzburg, Austria
[5] Lab Immunol & Mol Canc Res, Salzburg, Austria
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2016年 / 136卷 / 09期
关键词：
D O I：
10.1016/j.jid.2016.06.182
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
164
引用
收藏
页码：S189 / S189
页数：1
相关论文
共 50 条
  • [1] CRISPR/Cas9-mediated gene correction of COL7A1 in dystrophic epidermolysis bullosa
    Hainzl, S.
    Kocher, T.
    Murauer, E. M.
    Larcher, F.
    Steiner, M.
    Bauer, J. W.
    Koller, U.
    HUMAN GENE THERAPY, 2016, 27 (11) : A144 - A144
  • [2] CRISPR/Cas9 mediated gene correction of COL7A1
    Hainzl, S.
    Peking, P.
    Kocher, T.
    Murauer, E. M.
    Larcher, F.
    del Rio, M.
    Duarte, B. G.
    Steiner, M.
    Klausegger, A.
    Bauer, J. W.
    Reichelt, J.
    Koller, U.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S224 - S224
  • [3] Predictable CRISPR/Cas9-Mediated COL7A1 Reframing for Dystrophic Epidermolysis Bullosa
    Kocher, Thomas
    March, Oliver Patrick
    Bischof, Johannes
    Liemberger, Bernadette
    Hainzl, Stefan
    Klausegger, Alfred
    Hoog, Anna
    Strunk, Dirk
    Bauer, Johann Wolfgang
    Koller, Ulrich
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (10) : 1985 - +
  • [4] FAH GENE EDITING USING CRISPR/CAS9-MEDIATED REPAIR
    Darnell, J.
    Zhang, Q.
    Grompe, M.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (01) : 271 - 271
  • [5] Induced Liver Regeneration Enhances CRISPR/Cas9-Mediated Gene Repair in Tyrosinemia Type 1
    Zhang, Qing-Shuo
    Tiyaboonchai, Amita
    Nygaard, Sean
    Baradar, Kevin
    Major, Angela
    Balaji, Niveditha
    Grompe, Markus
    HUMAN GENE THERAPY, 2021, 32 (5-6) : 294 - 301
  • [6] CRISPR/Cas9-Mediated Gene Correction to Understand ALS
    Yun, Yeomin
    Ha, Yoon
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (11)
  • [7] CRISPR/Cas9-mediated gene editing for type 1 myotonic dystrophy
    Lo Scrudato, Mirella
    Martin, Samia
    Furling, Denis
    Bello, Ana Buj
    HUMAN GENE THERAPY, 2014, 25 (11) : A67 - A67
  • [8] CRISPR/Cas9-mediated COL7A1 editing in induced pluripotent stem cells from patients with recessive dystrophic epidermolysis bullosa
    Izmiryan, A.
    Lefort, N.
    Hovnanian, A.
    HUMAN GENE THERAPY, 2017, 28 (12) : A57 - A57
  • [9] Efficient repair of human genetic defect by CRISPR/Cas9-mediated interlocus gene conversion
    Yang, Fei
    Wang, Yiyun
    Wang, Qiudao
    Pang, Jingtao
    Liu, Guolong
    Yang, Yang
    Qin, Shenguang
    Zhang, Ying
    Lai, Yongrong
    Fu, Bin
    Zhu, Yating
    Wang, Mengyao
    Kurita, Ryo
    Nakamura, Yukio
    Liang, Dan
    Wu, Yuxuan
    LIFE MEDICINE, 2023, 2 (05):
  • [10] Precise and efficient editing of the COL7A1 gene in RDEB derived iPSCs with CRISPR/Cas9 and prime editing
    Inen, J.
    McGrath, P.
    Han, C.
    Bilousova, G.
    Kogut, I.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S120 - S120
12345